Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Thuot

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
L'Union Medicale Du Canada|January 1, 1973
[Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies]C Thuot, L Perron
L'Union Medicale Du Canada|August 1, 1974
[Chronic fibrinolysis in alcoholic cirrhosis]C Thuot, L Perron
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|January 1, 1971
Fibrinogen degradation products: a critical study of two assay methodsC Thuot, M J Larrieu
L'Union Medicale Du Canada|May 1, 1972
[Bleomycin: a new anti-tumor agent]C Thuot, R Poisson, L Perron
L'Union Medicale Du Canada|May 1, 1977
[Congenital antithrombin III deficiency: study of a Quebec family]C Thuot, D Marion, H Boucher
L'Union Medicale Du Canada|August 1, 1973
[Unusual symptomatology of Hodgkin's disease: massive invasion of the blood by abnormal cells]C Thuot, G Gariépy, M Monté, et al.
Annales De Chirurgie|January 1, 1996
[Reduction of blood loss in orthotopic liver transplantation with the use of aprotinin]G Légaré, A Roy, M Dagenais, et al.
Nephron|January 1, 1994
Severe skin necrosis associated with heparin in hemodialysisM Leblanc, L F Roy, L Legault, et al.
Canadian Medical Association Journal|December 3, 1977
Treatment of resistant ascites by continuous ultrafiltration--reinfusion of ascitic fluidJ P Villeneuve, C Thuot, D Marleau, et al.
L'Union Medicale Du Canada|June 1, 1985
[The NSABP. National Surgical Adjuvant Project for Breast and Bowel Cancers. (Definition, role, methodology, therapeutic trials, results, philosophy)]S Legault, R Poisson, P Franchebois, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
L'Union Medicale Du Canada|January 1, 1973
[Measurement of fibrinogen degradation products: its usefulness in consumption coagulopathies]C Thuot, L Perron
L'Union Medicale Du Canada|August 1, 1974
[Chronic fibrinolysis in alcoholic cirrhosis]C Thuot, L Perron
Revue Europeenne D'Etudes Cliniques Et Biologiques. European Journal of Clinical and Biological Research|January 1, 1971
Fibrinogen degradation products: a critical study of two assay methodsC Thuot, M J Larrieu
L'Union Medicale Du Canada|May 1, 1972
[Bleomycin: a new anti-tumor agent]C Thuot, R Poisson, L Perron
L'Union Medicale Du Canada|May 1, 1977
[Congenital antithrombin III deficiency: study of a Quebec family]C Thuot, D Marion, H Boucher
L'Union Medicale Du Canada|August 1, 1973
[Unusual symptomatology of Hodgkin's disease: massive invasion of the blood by abnormal cells]C Thuot, G Gariépy, M Monté, et al.
Annales De Chirurgie|January 1, 1996
[Reduction of blood loss in orthotopic liver transplantation with the use of aprotinin]G Légaré, A Roy, M Dagenais, et al.
Nephron|January 1, 1994
Severe skin necrosis associated with heparin in hemodialysisM Leblanc, L F Roy, L Legault, et al.
Canadian Medical Association Journal|December 3, 1977
Treatment of resistant ascites by continuous ultrafiltration--reinfusion of ascitic fluidJ P Villeneuve, C Thuot, D Marleau, et al.
L'Union Medicale Du Canada|June 1, 1985
[The NSABP. National Surgical Adjuvant Project for Breast and Bowel Cancers. (Definition, role, methodology, therapeutic trials, results, philosophy)]S Legault, R Poisson, P Franchebois, et al.
Pageof 2